Safety and Dose Ranging Study for OWL-EVO1 as a Lung Cancer EVOC® Probe (Evolution)
Clinical trial NCT05510674 · COMPLETED
Trial details
- NCT number
- NCT05510674
- Sponsor
- Owlstone Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-06
- Primary completion
- 2023-09-20
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.